Progressive multifocal leukoencephalopathy in a patient treated with natalizumab - sprookjes - yvandenbroek - TriplyDB

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

http://www.wikidata.org/entity/Q28255536

about

Multiple Sclerosis: Where Will We Be in 2020?Natalizumab for relapsing remitting multiple sclerosis Natalizumab for induction of remission in Crohn's disease Natalizumab for induction of remission in Crohn's disease Identification of targets and new developments in the treatment of multiple sclerosis--focus on cladribine CMX001 (1-O-hexadecyloxypropyl-cidofovir) inhibits polyomavirus JC replication in human brain progenitor-derived astrocytes Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain Identification of a third human polyomavirus Natalizumab: A new treatment for relapsing remitting multiple sclerosis Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy The role of vedolizumab in patients with moderate-to-severe Crohn's disease and ulcerative colitis Alzheimer's Disease: Exploring the Role of Inflammation and Implications for Treatment Neuroimaging of Natalizumab Complications in Multiple Sclerosis: PML and Other Associated Entities Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease Treatment-related progressive multifocal leukoencephalopathy: current understanding and future steps Multiple sclerosis-a quiet revolution The importance of mouse models to define immunovirologic determinants of progressive multifocal leukoencephalopathy Benefits versus risks of latest therapies in multiple sclerosis: a perspective review An update on the use of natalizumab in the treatment of multiple sclerosis: appropriate patient selection and special considerations Progressive multifocal leukoencephalopathy: new concepts Design of oral agents for the management of multiple sclerosis: benefit and risk assessment for dimethyl fumarate Progressive multifocal leukoencephalopathy: an unexpected complication of modern therapeutic monoclonal antibody therapies Illuminating viral infections in the nervous system Designing biologic selectivity for inflammatory bowel disease--role of vedolizumab Risk Mitigation Strategies for Adverse Reactions Associated with the Disease-Modifying Drugs in Multiple Sclerosis Monoclonal antibodies and progressive multifocal leukoencephalopathy Natalizumab and the role of alpha 4-integrin antagonism in the treatment of multiple sclerosis The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic review Risk of Biologic Therapy-Associated Progressive Multifocal Leukoencephalopathy: Use of the JC Virus Antibody Assay in the Treatment of Moderate-to-Severe Crohn's Disease Therapeutic decisions in multiple sclerosis: moving beyond efficacy A novel CMKLR1 small molecule antagonist suppresses CNS autoimmune inflammatory disease Functional energetics of CD4+-cellular immunity in monoclonal antibody-associated progressive multifocal leukoencephalopathy in autoimmune disorders The long and evolving relationship between viruses and multiple sclerosis Neutrophils and immunity: challenges and opportunities Progressive multi-focal leucoencephalopathy - driven from rarity to clinical mainstream by iatrogenic immunodeficiency.Progressive Multifocal Leukoencephalopathy in HIV-Uninfected Individuals.Clinical Trials in Neurovirology: Successes, Challenges, and Pitfalls Cerebral white matter: neuroanatomy, clinical neurology, and neurobehavioral correlates PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section.

P2860

Q22252863-77D3D250-06AA-42FE-982D-7C84C6B83A07 Q24235861-0FC7D8E3-084E-45F9-96DF-A3AFAFF90AD5 Q24245190-EDCFBBF5-86A7-4579-ABFD-46BA1D09931D Q24246262-10A82DAF-68BD-4843-B9B8-C2603802FA48 Q24597369-0AC0566D-2863-4B55-88E0-55949579D3A9 Q24599841-BDB85ED9-A1E6-4135-9428-1211C574AFDF Q24619923-16C6A122-AAC7-4288-8A89-6178BA44CF21 Q24672044-6A876A0D-AA8A-4ADF-BD57-C392C3DF1FB1 Q24683014-1A222A9B-4E07-4401-984C-1749A518DC05 Q24683776-0888A239-8243-48E9-BAB0-AC37F57EC057 Q26748626-D21CBACB-F50F-4663-B0CB-EC787CD3CA24 Q26776157-7E916BFF-A342-4C68-B0AF-E50D5F87A6E6 Q26781389-B0D9776C-FDEC-4A42-837B-5D419F5DBC5B Q26822029-B48E2E9B-4E3C-4B1D-A1E9-3796DB178CCB Q26823444-4B21420A-D9F5-4603-BF17-9A6830807759 Q26826930-AFA7FD9E-F163-4EB1-993C-CC3BEFF82978 Q26859307-EAD69030-FDBF-4F47-81A5-755E48DBD391 Q26999417-68A0590B-2C54-4CC0-A488-FC2770FB1457 Q27009769-BBFD097E-0CDC-41CA-9D16-92BFA312EE1F Q27016148-D0F49BD4-508A-4313-B90B-514CF90BDC5F Q27021147-D611196C-1540-469E-A1E2-5FEA9F22A7D2 Q27028025-9391FD39-9124-4B12-AE94-C23CAEA28C21 Q27310280-F5DFA577-2B00-43A6-85F2-ED3D60B3C3D9 Q28083872-FC8BDC67-F7BE-4B12-8E34-1B6B9C22BCC4 Q28087414-80E09087-AFC4-449E-B44C-89B363EC20D5 Q28270413-4896CFAF-993A-456B-81F2-79458AC80383 Q28277470-8BF55A3C-4806-45FE-BBC6-48427145127B Q28299076-EE137FF3-96F7-422D-8E9B-5079B5DB4098 Q28534465-DAF28F31-558D-4BC9-B69F-EBA50811A181 Q28538974-D51CC7CA-AABD-482A-8050-92FEA9C424AC Q28541039-339BAF8A-099A-4A2B-A866-EE7EC8C3FCD7 Q28542368-0121AC4F-B0C6-4863-839B-38A9D038AC97 Q28740884-CA5295D1-8DA4-4A5D-AC56-EA0ABBEA7D37 Q29301310-9EF1D1A5-E098-4701-B722-FA1154183807 Q29617616-87CBFA5E-4E19-4212-916F-52EEEC123D7A Q30235523-68374350-D372-4186-BC23-99E9961B0F04 Q30245002-9EDFD45C-DA34-4EE7-B83A-F84AC60D7CE9 Q30250271-5F90E2D0-F5DA-4511-9FCA-9E83DEFC2CD9 Q30450267-7FBDC926-AE03-46CC-BA33-F353938F0713 Q30613846-A0DB031B-DD4F-4A67-9A23-A6CD1F5E743C

P2860

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

http://www.wikidata.org/entity/Q28255536

description

2005 nî lūn-bûn

@nan

2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

@ast

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

@en

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

@nl

type

label

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

@ast

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

@en

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

@nl

prefLabel

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

@ast

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

@en

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

@nl

P1433

Q28255536-9FCEEC2F-B001-47F5-805E-C896E6803DF6

P1476

Q28255536-D4F12DC8-1DC9-42F0-823A-FB84FED1BF90

P2093

Q28255536-2F5349AA-C3FC-4113-9C46-20EA33BBCD88

Q28255536-5D03C73C-AAC8-41EA-8DF3-3334EEABAF99

Q28255536-82D9CC3E-95F8-4E8F-97DE-07333D11A589

Q28255536-86C6650F-1AED-4CDE-B5BC-A0CA4B32C807

Q28255536-E3B4388F-00BE-48F2-B9D8-FB137448B687

P304

Q28255536-BC1B266B-9484-414A-ABB1-5C556C90FF52

P31

Q28255536-6EB52140-8B1C-4CEE-945A-E69A677A0694

P3181

Q28255536-D901D3E7-D7DD-4C02-9109-BE08D5D6193A

P356

Q28255536-A098C77A-6000-463A-BFC7-DF067BFF04D1

P407

Q28255536-368CD86E-F9B6-4EB8-9950-7CB20960E501

P433

Q28255536-12791E97-0876-48BC-88D5-E80E0F6C9247

P478

Q28255536-0E79A25B-2E94-404C-A73E-5B9AB5D2BDEE

P577

Q28255536-E9722BFE-62D8-4DB5-8C6F-263049112B51

P698

Q28255536-F339F5A2-27E1-4329-8BCB-FA8728ED0281

P921

Q28255536-98C6D111-0CFB-4976-A5C4-8BBF28A9812F

Q28255536-DB96E575-25D2-45B5-8D70-2423FDAAC36F

P3181

P356

P1433

The New England Journal of Medicine

P1476

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

@en

P2093

Andrew W Bollen

http://www.w3.org/2001/XMLSchema#string

Annette Langer-Gould

http://www.w3.org/2001/XMLSchema#string

Ari J Green

http://www.w3.org/2001/XMLSchema#string

Daniel Pelletier

http://www.w3.org/2001/XMLSchema#string

Scott W Atlas

http://www.w3.org/2001/XMLSchema#string

P304

375-81

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

121623

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA051847

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

353

http://www.w3.org/2001/XMLSchema#string

P577

2005-07-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15947078

http://www.w3.org/2001/XMLSchema#string

P921

progressive multifocal leukoencephalopathy